Table 2.
Recommendations for when to initiate antiretroviral therapy for symptomatic HIV-infected patients.
Source of recommendation [reference] | Date of publication |
CD4 cell count, cells/mm3 |
Plasma HIV RNA level, copies/mL |
---|---|---|---|
International AIDS Society–USA Panel [30] | Jul 1998 | Any | >5000–10,000 |
International AIDS Society–USA Panel [31] | Jan 2000 | <500 | >5000–30,000 |
Panel on Clinical Practices for Treatment of HIV [32] | Feb 2001 | <350 | >30,000 |
Panel on Clinical Practices for Treatment of HIV [33] | May 2002 | <350 | >55,000 |
International AIDS Society–USA Panel [34] | July 2002 | >200 | >50,000–100,000 |
Panel for Clinical Practices for Treatment of HIV [35] | Nov 2003 | 200–350 | >55,000 |
WHO guidelines, 2003 revision [36] | Dec 2003 | ≤200 | NA |
NOTE. NA, not applicable; WHO, World Health Organization.